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Abstract 
 
The secondary dystroglycanopathies are characterised by the hypoglycosylation of alpha 
dystroglycan, and are associated with mutations in at least 18 genes which act on the 
glycosylation of this cell surface receptor rather than the Dag1 gene itself. At the severe end 
of the disease spectrum, there are substantial structural brain defects, the most striking of 
which is often cobblestone lissencephaly.  The aim of this study was to determine the gene-
specific aspects of the dystroglycanopathy brain phenotype through a detailed investigation 
of the structural brain defects present at birth in three mouse models of dystroglycanopathy 
- the FKRP
KD
 which has an 80% reduction in Fkrp transcript levels; the Pomgnt1null, which 
carries a deletion of exons 7-16 of the Pomgnt1 gene; and the Large
myd 
mouse, which carries 
a deletion of exons 5-7 of the Large gene. We show a rostrocaudal and mediolateral 
gradient in the severity of brain lesions in FKRP
KD
, and to a lesser extent Pomgnt1null mice.  
Furthermore, the mislocalisation of Cajal-Retzius cells is correlated with the gradient of 
these lesions and the severity of the brain phenotype in these models.  Overall these 
observations implicate gene specific differences in the pathogenesis of brain lesions in this 
group of disorders. 
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Introduction 
The dystroglycanopathies are a heterogeneous group of neuromuscular diseases, associated 
with mutations in genes that encode proteins implicated in the glycosylation of alpha 
dystroglycan rather than the Dag1 gene itself. As a consequence these are referred to as 
‘secondary’ rather than primary. Rare mutations in the Dag1 gene have been reported but 
they amount to only a few cases due most likely to embryonic lethality (27). To date, 
mutations in at least 18 genes have been associated with the secondary 
dystroglycanopathies, many of which encode either proven or putative glycosyl 
transferases. These include POMGNT1, which is a demonstrated glycosyltransferase adding 
N-acetylglucosamine (88);  LARGE, a bifunctional glycosyltransferase that alternately 
transfers xylose and glucuronic acid and confers ligand binding (25, 38, 50, 79),  and Fukutin-
related protein (FKRP), the function of which is currently unknown (7, 10, 12). Interestingly, 
mutations in these genes are associated with a wide spectrum of clinical phenotypes, which 
at the severe end of the disease spectrum include congenital muscular dystrophies with 
structural brain defects, exemplified by Walker Warburg syndrome (WWS) OMIM 236670, 
Muscle Eye Brain disease (MEB) OMIM 253280, congenital muscular dystrophy type 1 C 
(MDC1C) OMIM 606612 and congenital muscular dystrophy type 1D (MDC1D) OMIM 
608840. Severely affected patients typically show a range of structural brain abnormalities 
associated with defects in neuronal migration, particularly type II (cobblestone) 
lissencephaly, which is strongly suggestive of this group of disorders (17).  In addition, 
patients may show cortical and cerebellar dysplasia, polymicrogyria and hydrocephalus, 
with evidence of dysmyelination on MRI (9). Work in dystroglycanopathy patients and 
mouse models, strongly suggests that the hypoglycosylation of alpha dystroglycan is central 
to the pathogenesis via its effect on the structural integrity of the pial basement membrane 
during cortical development (56, 59).  
Dystroglycan (DG) is transcribed from a single gene (Dag1) and undergoes post-translational 
cleavage to produce the peripheral membrane protein alpha dystroglycan, and the 
transmembrane protein beta dystroglycan, which are non-covalently linked (37).  Alpha 
dystroglycan undergoes extensive O-linked mannosylation of its central mucin-rich domain, 
and these glycan chains mediate binding to extracellular matrix proteins such as laminin 
(20), agrin (23, 86), neurexin (74),  pikachurin (69) and perlecan (57).  Beta dystroglycan in 
Page 3 of 37
Brain Pathology Editorial Office, Blackwell Publishing, Oxford, UK
Brain Pathology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
4 
 
turn interacts with the cell’s actin cytoskeleton via dystrophin, utrophin, ezrin or plectin (57).  
Together, alpha and beta dystroglycan effectively link the cytoskeleton to the extracellular 
matrix.  The DG complex has been previously demonstrated to play a primary role in the 
deposition, organisation and turnover of basement membranes (31).   
Targeted deletion of dystroglycan in the brain during development, or mutations of known 
or putative glycosyltransferases involved in the glycosylation of alpha dystroglycan, have 
both been demonstrated previously to recapitulate many aspects of WWS and MEB, 
indicating dystroglycan as central to the disease pathogenesis (1, 25, 49, 58). However, in 
the absence of comparative studies it is unclear whether some aspects of the 
neuropathologic lesions are gene specific.  In order to answer this question, we have now 
undertaken a detailed investigation of the structural brain defects in three 
dystroglycanopathy mouse models – the FKRP-Neo
Tyr307Asn 
(FKRP
KD
) which has an 80% 
reduction in Fkrp transcript levels (1); the Pomgnt1null mouse, which carries a deletion of 
exons 7-16 of the Pomgnt1 gene; and the Large
myd
 mouse, which carries a deletion of exons 
5-7 of the Large gene (25).  
Materials and Methods 
Mouse models and Genotyping. 
Three dystroglycanopathy mouse models were compared – the FKRP-Neo
Tyr307Asn 
(FKRP
KD
) 
(1); the Pomgnt1null, and the Large
myd
 (25). The POMGnT1null strain used for this piece of 
work was generated by the Functional Glycomic Consortium (Pomgnt1
tm1.1Cfg
/Mmucd) and 
has a deletion of exons 7-16 of the Pomgnt1 gene.  All animal experiments were carried out 
under license from the Home Office (UK) in accordance with The Animals (Scientific 
Procedures) Act 1986 and were approved by the Royal Veterinary College ethical 
committee. Mice were sacrificed at P0 and genotype was confirmed by PCR.  Primers were 
as follows: for FKRP
KD
 mice, Fkrp forward: GTTGTGCTTAAACCACCTTC; Fkrp neo forward: 
GGTGGGATTAGATAAATGCC; Fkrp reverse: CTAGGAGGTTGAGGATGATGG. Fkrp forward and 
Fkrp reverse amplified the wild type gene, Fkrp neo forward and Fkrp reverse the mutant 
gene. For Pomgnt1null mice, primer 1607: CTGGGCCCACACAAGTCATGA; primer 1608: 
TCTCTGCTCAAACGCTGCCC; primer 1796: TTGATGCTGTTATAGAGGCC.  Primers 1607 and 
1608 amplified the wild type gene, primers 1607 and 1796 the mutant gene.  For the 
Large
myd
, primers were MydF3: ATCTCAGCTCCAAAGGGTGAAG; MydR2: 
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GCCAATGTAAAATGAGGGGAAA; GT4F: GGCCGTGTTCCATAAGTTCAA; GT4R: 
GGCATACGCCTCTGTGAAAAC.   MydF3 and MydR2 primers amplified the mutant gene and 
GT4F and GT4R the wild type. 
Histology  
The heads were fixed in Bouin’s fixative (Sigma) for 24hours at room temperature, before 
being processed and embedded in paraffin wax. Samples were serially sectioned at 5µm, 
with sections collected onto charged slides (Superfrost Plus, VWR).  At approximately 50µm 
intervals, sections were stained with haematoxylin and eosin (HE).  Intermediate levels were 
retained for immunohistochemistry. 
Immunohistochemistry 
Primary antibodies used in the study were as follows: rabbit anti-brain lipid binding protein 
1:300 (raised against human brain lipid binding protein, rabbit polyclonal, ABN14, Millipore), 
mouse anti-reelin 1:1000 (raised against recombinant fusion protein, corresponding to 
amino acids 164-496 of mouse reelin, monoclonal clone name G10 Abcam), and anti- alpha 
dystroglycan (IIH6)1:200 (raised against rabbit skeletal muscle membrane preparation, 
monoclonal, clone name IIH6C4, Millipore). Sections were deparaffinised and rehydrated. 
Heat-induced epitope retrieval (HIER) was performed in Tris-EDTA (10 mM Tris-HCl, 1 mM 
disodium EDTA, pH 8.0).  All primary antibodies were diluted in phosphate buffered saline 
containing 0.05% tween 20 (Sigma) and 5% goat serum (Sigma), and sections were 
incubated for 1 hour at room temperature.  Visualisation of antibody binding used the 
Envision™ HRP-conjugated polymer system (DAKO).  
Generation of brain maps 
Photomicrographs of HE stained sections were captured on a Leica DM4000B bright field 
microscope using a Leica DC500 camera. Using Photoshop 5 (Adobe), maps were generated 
to allow comparison of similar levels.  
Cajal-Retzius cell counts 
The number of Cajal-Retzius (CR) cells were counted at two brain levels – the rostral cortex, 
at the level of the corpus callosum; and the caudal cortex, at the level of the hippocampus.  
To ensure consistency, levels were matched using appropriate anatomical landmarks.  The 
number of CR cells in the cortex were counted in each section.  For each mouse, three serial 
reelin-stained sections (5µm apart) were counted at rostral and caudal levels, and the mean 
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number of CR cells per section was calculated. Values were compared using a one way 
ANOVA with Dunnett’s multiple comparisons.   
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Results 
Lesions within the cortex of FKRP
KD 
mice follow a rostrocaudal gradient; FKRP
KD
 mice exhibit 
the most severe brain phenotype and Large
myd
 mice the mildest. 
In FKRP
KD
, Pomgnt1null and Large
myd
 mice, the rostral cortex (overlying the olfactory lobes), 
was disrupted.  In FKRP
KD 
mice, this was characterised by a complete absence of laminar 
organisation, with no obvious structure to the cortical plate, and apparent fusion of the 
interhemispheric fissure.  In Pomgnt1null mice, as in the FKRP
KD
, this could be indicative of 
non-cleavage of the prosencephalon.  However, previous reports in other 
dystroglycanopathy models show that the hemispheres develop independently (60). In 
contrast to FKRP
KD 
mice, some cortical plate structure, subjacent to a substantial, 
disorganised, extracortical layer, was apparent in the Pomgnt1null mice.  Large
myd
 mice at 
this level were phenotypically distinct - the cortical hemispheres were separate, and 
multifocal defects were present, with migration of neurons and glial cells through into a 
narrow, extracortical layer (Figure 1A-D). 
At the level of the corpus callosum, apparent fusion of the cortical hemispheres was still 
evident in FKRP
KD
 and Pomgnt1null mice. In both FKRP
KD  
and Pomgnt1null mice, 
disorganisation was more pronounced laterally.  Similar to the more rostral cortex, 
Large
myd 
mice exhibited focal disorganisation in the cortical plate, with heterotopic neuronal 
and glial cells forming a narrow, subarachnoid extracortical layer (Figure 1E-H).  In addition, 
examination of higher magnification images at this level (Figure 2) shows that normal 
leptomeningeal architecture is substantially disrupted in FKRP
KD
 and Pomgnt1null mice.  In 
wild type mice, the leptomeninges are readily apparent, comprising the superficial 
arachnoid mater, the subarachnoid space (containing the subarachnoid vessels) and the pia 
mater. In FKRP
KD 
and Pomgnt1null mice, and to a lesser degree, Large
myd 
mice, there was 
little, if any distinction between these layers.  The arachnoid was apparent at the cortical 
surface, and vessels were encompassed by heterotopic neurons and glial cells within the 
extracortical layer.  The pia was not apparent in FKRP
KD
 and Pomgnt1null mice (Figure 2). 
At the level of the hippocampus, in FKRP
KD
 mice the cortical plate was more established 
towards the midline, than observed at more rostral levels of the cortex, although lateral 
aspects of the cortex were still extensively disrupted.  In Pomgnt1null mice at this level, the 
cortex was more organised laterally. Large
myd
 mice continued to exhibit the focal defects in 
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the cortical plate and the narrow extracortical layer present elsewhere in the cortex.  
Dilation of the lateral ventricles (hydrocephalus) was present in a proportion of FKRP
KD
 (3/5) 
and, less markedly, in Pomgnt1null mice (2/5) at this time point, but was not observed in 
Large
myd 
 mice or wild type controls (Figure 1I-L).  The dentate gyrus of the hippocampus was 
disrupted in a subset (2/5) of FKRP
KD 
mice (Figure 3).  Despite reports of disruption to the 
hippocampus in adult Large
myd
 and another strain of Pomgnt1
-/-
 mice in the literature (34, 
47), lesions were not identified in these strains at P0 in the current study. 
The inferior and superior colliculi, were disrupted in all three lines of
 
mice.  Lesions in 
Pomgnt1null and Large
myd
 mice were characterised by focal defects with obliteration of the 
subarachnoid space by heterotopic neuroglial cells.  In FKRP
KD
 mice, there was some 
organisation in the midline, but laterally, substantial defects in the pia enabled large 
numbers of cells to form a prominent subarachnoid layer (Figure 1M-P; Figure 4). 
Subtle cerebellar lesions, characterised by disruption to the external granule cell layer, were 
present in 2/5 FKRP
KD 
mice and 1/5 Pomgnt1null mice.  Cerebellar lesions were not observed 
in Large
myd 
mice (Figure 1M-P), however sagittal sections may allow better assessment of 
cerebellar pathology. 
Distinct patterns in lesion location/severity were observed; excluding the olfactory lobes of 
the brain, the FKRP
KD
 and Pomgnt1null mice showed rostrocaudal and lateromedial gradient 
in the severity of cortical lesions, with the greatest degree of dyslamination in the rostral 
and lateral aspects of the cortex.  Despite the similarities in lesion localisation, the brain 
phenotype was most substantial in FKRP
KD 
mice. Contrary to the other models, 
Large
myd  
mice exhibited lesions of similar character and severity throughout the cortex and 
midbrain (Figure 1). 
Disruption to the radial glial scaffold is present in all of the mouse models of 
dystroglycanopathy, but the glia limitans is most extensively disrupted in FKRP
KD  
mice. 
In wild type mice elongate BLBP-positive processes extended to the surface of the brain, 
where there was diffuse, continuous subpial staining of the radial glial end feet, which form 
the glia limitans (Figure 5A.  A, E, I, M).   
In FKRP
KD 
mice, staining in the ventricular zone was similar to that observed in wild type 
mice, however, radial glial processes were often haphazardly arranged, there was no subpial 
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staining (complete disruption of the glia limitans) and scattered BLBP-positive foci (radial glial 
processes) were present within the disorganised cortical plate and extra cortical layer.  The 
tectum was less affected than the cortex, but significant abnormalities were still apparent.  
Although relatively organised centrally and dorsomedially, discontinuous laminar staining 
was apparent more laterally and large numbers of heterotopic neurons and glial cells were 
present superficial to the glia limitans, expanding the sub arachnoid space (Figure 5A. B, F, J, 
N). 
In Pomgnt1null mice, disruption to the glia limitans was still substantial, but there remained 
some foci of laminar staining (superficial to more organised areas of the cortical plate). In 
the rest of the cortex, and in the substantial extracortical layer present above these laminar 
foci of displaced glia limitans, were scattered BLBP-positive areas, similar to those observed 
in the FKRP
KD
 (radial glial processes).  In the tectum, there was relatively little disruption to 
the laminar architecture, but multifocally, BLBP staining was discontinuous, and neuroglial 
cells were seen extending through the defects and expanding the subarachnoid space 
(Figure 5A. C, G, K, O) 
In the cortex of Large
myd
 mice, the glia limitans was largely continuous, although separated 
from the arachnoid by heterotopic neurons and glial cells. Multifocally there were defects in 
the glia limitans, which were associated with disorganisation of the underlying cortical plate, 
and in these areas, neurons and glial cells were visible migrating through the defects 
expanding the subarachnoid space and forming a narrow extracortical layer.   The glia 
limitans in the tectum of Large
myd
 mice displayed multifocal discontinuities in BLBP staining 
associated with migration of neurons and glial cells through into the subarachnoid space to 
form an extracortical layer (Figure 5A. D, H, L, P).   
These findings indicate that there are substantial differences in the degree of disruption to 
the glia limitans between the different mouse models which correlates with the overall 
severity of the brain phenotype.  Disruption was most pronounced in FKRP
KD
 mice and 
mildest in Large
myd
 mice.  Pan laminin labelling to show the location of the glial limitans is 
shown in Figure 5B. 
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Expression of the IIH6 epitope of alpha dystroglycan 
Expression of the IIH6 epitope of alpha dystroglycan was widespread in wild type mice 
(Figure 6).  In addition to intense sarcolemmal staining in muscle, and fine laminar 
immunoreactivity at the pial basement membrane, there was intense staining of the 
basement membrane of blood vessels within the brain and the choroidal epithelium. 
Of the dystroglycanopathy models examined, Pomgnt1null mice showed the most 
pronounced, diffuse loss of IIH6 immunoreactivity.  Loss of immunoreactivity was complete 
and all tissues examined were immunonegative. 
In FKRP
KD 
mice a small, residual amount of sarcolemmal IIH6 immunoreactivity was 
observed within some, but not all, muscle groups. Immunolabelling was much less intense 
than that seen in wild type mice stained concurrently.  Muscle types which continue to 
exhibit some sarcolemmal staining included the tongue, masticatory and laryngeal muscles.  
Interestingly, IIH6 immunoreactivity was not observed at the sarcolemma of subcutaneous 
muscles or extraocular muscles.  Immunolabelling of the pial basement membrane and the 
basement membrane of the choroidal epithelium was absent. 
In Large
myd
 mice, IIH6 immunolabelling was not apparent at the pia, similar to the 
Pomgnt1null and the FKRP
KD
 mice.  However, labelling of a similar distribution and intensity 
to that observed wild type mice was observed at the choroidal epithelium.  In addition, in 
Large
myd 
mice, IIH6 immunolabelling was observed in multiple other epithelial structures, 
including the skin, developing tooth, salivary gland, choroidal epithelium and respiratory 
epithelium. 
Mislocalisation of Cajal-Retzius cells in mouse models of dystroglycanopathy 
Cajal-Retzius cells arise early in brain development and are key to the ordered migration of 
neurons within the cortex. They produce reelin - an extracellular glycoprotein which has 
roles in neuronal migration, radial glial differentiation and providing a “stop signal” to 
prevent over migration of neurons (54). 
In wild type mice, Cajal-Retzius (CR) cells were present multifocally within the superficial 
molecular layer, orientated parallel to the surface.  However, in FKRP
KD
 mice the majority of 
CR cells were located around the anterior cerebral artery.  Scattered CR cells were present 
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within the disorganised cortical plate.  Only rarely were CR cells apparent in more lateral 
aspects of the cortex.  In Pomgnt1null mice, there was still some clustering of CR cells around 
the anterior cerebral artery, but a larger proportion of cells extended away from the 
midline, although they were still organised randomly and within the extracortical layer.  In 
Large
myd
 mice, CR cell localisation was more orderly, and although often CR cells were 
present within the extracortical layer, they assumed the tangential orientation and the 
discontinuous, laminar staining pattern of the wild type in some areas (Figure 7, A-H).   
Cell counts identified a statistically-significant decrease in the number of CR cells in the 
rostral cortex (level of the corpus callosum) in FKRP
KD
 and Pomgnt1null mice (p = 0.0002 and 
p = 0.0017, respectively).  In FKRP
KD
 mice, there was a concurrent, statistically-significant (p 
= 0.046) increase in the number of CR cells at the level of the hippocampus.  In Large
myd
 
mice, there was no difference in the number of CR cells (when compared with wild type 
mice) at either level (Figure 7I, J).  These findings may suggest either a local (failure of 
migration) or total (failure of differentiation/increased loss) decrease in the number of CR 
cells in the cortex. 
Discussion 
FKRP, POMGNT1 and LARGE are demonstrated or putative glycosyltransferases involved in 
the post-translational modification of alpha dystroglycan (7, 10, 12, 25, 50, 79, 88). They are 
located within the Golgi apparatus, and are hypothesised to work sequentially, with each 
involved in the addition of a separate sugar moiety (11, 21, 38, 42, 88).  They represent 
three of the 18 genes currently implicated in the dystroglycanopathies, mutations in which 
result in the hypoglycosylation of alpha dystroglycan (5, 6, 10, 13, 14, 44, 45, 50, 51, 66, 73, 
78-81, 83, 84, 87, 88).   At the severe end of the dystroglycanopathy spectrum (WWS and 
MEB), patients exhibit substantial structural brain abnormalities, including neuronal 
migration defects (manifest as pachygyria or cobblestone lissencephaly), hydrocephalus and 
cerebellar defects (18).   
FKRP
KD
 and Pomgnt1null brain lesions exhibit a rostrocaudal and mediolateral gradient in 
severity 
There was a substantial variation in brain phenotype between the FKRP
KD
, Pomgnt1null
 
and 
Large
myd
 models, to the degree that the models could be distinguished based on 
morphology alone.  This is consistent with reports from Devisme et al. (16), who found that 
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morphological classification of neuropathologic findings in foetuses with cobblestone 
lissencephaly enabled accurate orientation of genetic screening, and indicating that the 
mouse models largely provide a good representation of the  human disease (16).   
Mice from all strains exhibited distinct patterns of lesions within the brain, which varied 
according to the mutation.  FKRP
KD
 and Pomgnt1null mice exhibited a rostrocaudal gradient 
in the severity of brain lesions, with lesions most pronounced in the rostral cortex and 
progressively milder more caudally. Additionally, there were differences mediolaterally, 
with cortical organisation greatest towards the midline, and disruption extending laterally.  
Unlike the other models examined, Large
myd
 mice did not exhibit this gradient of lesions – 
defects in the Large
myd
 were multifocal and present throughout the brain.  
Although a gradient of lesion severity has not been previously reported cases of 
cobblestone lissencephaly in patients, specific lesion localisation is reported in other human 
neuronal migration defects.  Loss of function mutations in the G-protein coupled receptor 
56 (GPR56) in patients is associated with the autosomal recessive brain abnormality bilateral 
frontoparietal polymicrogyria (BFFP), in which a neuronal migration defect is isolated to the 
frontal and parietal lobes of the brain (15).  A gradient of lesions is also observed in cases of 
classical lissencephaly.  LIS1 mutations produce lesions which are more severe in the 
occipital lobe (posterior-predominant), whereas those produced by DCX1 mutations are 
more severe in the frontal lobes (anterior-predominant) (63, 67). The mechanisms 
underlying the specific lesion localisation in BFFP or classical lissencephaly are unknown, 
although in the case of classical lissencephaly is it is believed to be due to Dcx and Lis1 
having distinct, but related roles in signal transduction pathways (63).  
Previously, there has been the suggestion of a medial-lateral gradient in lesion severity in 
conditional dystroglycan null mice that corresponds to the time point at which dystroglycan 
is lost (70).  In Nestin cre-DG null mice, where there is deletion of dystroglycan from around 
E10.5, loss of lamination and neuroglial heterotopia extend through to the lateral cortex and 
pyriform lobe; whereas in GFAP cre-DG null mice, in which dystroglycan is deleted around 
E13.5, lesions are focal and present only in the medial cortex (70).  The differences in lesion 
gradient observed in FKRP
KD
, Pomgnt1null and Large
myd 
mice may therefore represent 
temporal differences in the requirement for these proteins, or in the case of the Large
myd
, 
may suggest the ability of Large homolog Large2 to compensate for the loss of Large early in 
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development.  The latter point is of particular relevance as in this work, immunolabelling for 
the IIH6 epitope of alpha dystroglycan revealed continued expression of glycosylated alpha 
dystroglycan in the choroid plexus of this model. 
 
The degree of Cajal-Retzius cell disruption is correlated with the severity of the brain lesions 
 
In FKRP
KD
, Pomgnt1null and Large
myd 
mice,
 
the rostrocaudal and mediolateral gradient of 
brain lesions c rrelates with the degree of Cajal-Retzius cell disruption observed in each of 
the mouse strains. The areas of the cortex with the most substantial dyslamination are 
those with the lowest number of Cajal-Retzius cells (Figure 7).  FKRP
KD 
mice, which exhibit 
the most substantial mislocalisation of Cajal-Retzius cells, also have the most pronounced 
gradient of lesions, whereas in Large
myd
 mice, which have minimal Cajal-Retzius cell 
mislocalisation, a gradient is not apparent.  Cajal-Retzius cells are one of the earliest cell 
populations produced in the developing brain, arising from the caudomedial pallium 
(primarily the cortical hem) and undergoing tangential migration to occupy the marginal 
zone of the entire cortex (52, 53).  
Reelin is an extracellular glycoprotein produced by the Cajal-Retzius cells, and this protein 
has a number of critical roles in brain development.  Reeler mice carry a mutation in the 
Reln gene which encodes reelin.  These mice exhibit marked cortical disruption, 
disorganisation and inversion of cell layers, with substantial malformation of the radial glial 
scaffold; and patients with mutations in RELN exhibit pachygyria with severe cerebellar 
hypoplasia, phenotypically similar to the lesions seen in patients with WWS and MEB (28, 
35, 82).  It has been demonstrated that reelin induces a radial glial phenotype in 
neuroepithelial progenitors via activation of Notch-1 (41), and it arrests neuronal migration 
and promotes normal cortical lamination by providing a stop signal through the binding of 
α3β1 integrin (19, 48).  Reelin is also responsible for the regulation of radial glial cells – in the 
Emx1/2 and p73 knockout mice, where there is premature loss of Cajal-Retzius cells, and in 
animals where the Cajal-Retzius cells have been chemically ablated, there are decreased 
numbers of radial glial cells and premature transformation of radial glial cells into astrocytes 
(55, 71, 75).   
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The severity of disruption to the radial glial scaffold is associated with Cajal-Retzius cell 
mislocalisation 
 
Brain lipid binding protein (BLBP) is expressed by radial glial cells.  It is a cytoplasmic protein 
involved in fatty acid uptake, transport and metabolism (22).  BLBP expression, and the 
radial glial phenotype, is induced in neuroepithelial progenitors via reelin-mediated 
activation of Notch-1 (41).  Radial glial cells are bipolar cells with elongated processes which 
extend from the ventricular zone to the pial basement membrane, spanning the developing 
cortex.  This provides a scaffold along which neurons migrate - an integral component of the 
‘inside out’ development of the mammalian cortex (64).  In addition, radial glial cells provide 
a progenitor population (29, 61, 77). Radial glial foot processes form the glia limitans (the 
glial limiting membrane) in the developing brain, and as such form part of the blood brain 
barrier (64).  Defects in the radial glial scaffold, either physical, chemical, or genetic; 
produce substantial abnormalities in neuronal migration and layering, causing neuronal 
migration defects and cobblestone lissencephaly, and recapitulate the brain lesions seen in 
patients with WWS and MEB caused by mutations in in FKRP, POMGNT1 and  LARGE  (61, 
62, 65). 
In FKRP
KD
, Pomgnt1null and Large
myd
 mice at P0, there was disruption to the radial glial end 
feet (glia limitans), most extensive in the FKRP
KD
, which was characterised by alterations in 
the pattern and distribution of BLBP-staining.  This, alongside cortical dysplasia with 
obliteration of the subarachnoid space, neuroglial heterotopia and the apparent fusion of 
the  interhemispheric fissure, indicate radial glial cells are substantially disrupted in all of the 
examined models of dystroglycanopathy, but most notably in the FKRP
KD
. Again, the areas of 
most substantial disruption to glial scaffold were those with the lowest number of Cajal-
Retzius cells. Whilst in humans additional defects in the subpial granular layer originally 
described by Brun may contribute to these alterations,  this layer was not examined in this 
study as it is much more developed in human than other mammals (24).  
FKRP
KD
, Pomgnt1null and Large
myd 
mice all exhibit mislocalisation of Cajal-Retzius cells, 
however, the relative decrease in the number of Cajal-Retzius cells in the rostral cortex, with 
the concurrent increase in the area of the hippocampus in FKRP
KD
 and Pomgnt1null mice, 
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suggests that there is failure of tangential migration of Cajal-Retzius cells in these models.  
This is in marked contrast to the brain lesions observed in Large
myd
 mice. 
Given the role Cajal-Retzius cells and reelin play in neuronal migration and the organisation 
of the radial glia, and the correlation between the degree of Cajal-Retzius cell 
mislocalisation and the location and severity of the brain lesions observed, this suggests that 
Cajal-Retzius cell mislocalisation may have a significant role in the manifestation of the brain 
phenotype.  In addition, it suggests that factors affecting Cajal-Retzius cell migration may 
underpin the pathogenesis of the structural brain defects in FKRP
KD 
and Pomgnt1null mice, 
but not Large
myd 
mice. Radial glial fibres form the initial migratory microcolumns, whilst the 
migration of inhibitory interneurons initiated prior to radial migration, forms the marginal 
zone of the preplate which includes Cajal Retzius cells, molecular zone and subplate neurons 
(68). Horizontal lamination in the newborn FKRP
KD
 brain as detected using markers such as 
Tbr1 and Ctip2 is clearly evident although it shows a disturbed pattern (3).  
Previously, it has been hypothesised that, as disruption to the glia limitans and neuronal 
migration defects are largely localised to the areas of the brain which undergo most 
pronounced and rapid expansion during development. In agreement with this the brain 
lesions in dystroglycanopathy models were reported to develop due to failure of the radial 
glial cells to appropriately organise the basement membrane during periods of rapid cortical 
expansion (60).   This idea was strengthened by data from a Pomgnt1
-/-
 strain, whereby the 
basement membrane was initially normal and was intact at E11.5, but abnormalities were 
apparent by E13.5 (36).  Similarly, in Nestin cre-DG null mice, in which dystroglycan was 
knocked out from E10.5, abnormalities in the basement membrane were first apparent at 
E13.5 (70).   
Radial glial endfeet retraction could potentially account for the lesions observed in Large
myd 
mice, in which Cajal-Retzius cells are mislocalised but do not exhibit a failure of migration. 
However, our observations of a disruption in Cajal-Retzius cell migration in FKRP
KD
 and 
Pomgnt1null mice are suggestive of a more complex pathogenesis albeit not one which 
excludes a role for the radial glia. Indeed previous work in which the radial glial scaffold was 
disrupted without impacting on either the meninges or basement membrane integrity 
demonstrated a primary role for radial glia in Cajal Retizus cell localisation (43).  
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The mechanisms involved in the migration of Cajal-Retzius cells from their birthplace to 
cover the marginal zone of the entire cortex are not fully understood, although the process 
is known to be influenced by a number of factors. The leptomeninges are central to the 
orchestration of this process, through both their physical presence and through chemokine 
signalling via the CXCL12/CXCR4 pathway (8). Surgical, chemical or genetic disruption of the 
leptomeninges produces Cajal-Retzius cell degeneration with pronounced disruption in 
Cajal-Retzius cell localisation, further indicating the importance of the leptomeninges to 
Cajal-Retzius cells (30, 40, 48, 75, 76).  In addition, the leptomeninges are morphologically 
abnormal in the mouse models of dystroglycanopathy, as identified in this study and in a 
Pomgnt1
-/- 
mouse model in work by Yang et al. (85).  Taken together, this implicates a role 
for abnormalities in leptomeningeal cells in the pathogenesis of the dystroglycanopathies.   
Expression of the IIH6 epitope of alpha dystroglycan varies between mouse models of 
dystroglycanopathy 
Despite the presence of significant brain phenotypes in FKRP
KD
, Pomgnt1null and Large
myd
 
mice; and published muscle and eye phenotypes in these models (1, 2, 32, 34), there was 
significant variation in the expression of th  glycoepitope of alpha dystroglycan recognised 
by the IIH6 antibody between them.  In both FKRP
KD
 and Pomgnt1null mice, no IIH6 
immunolabelling was identified in the brain.   
In the brain of Large
myd
 mice, the IIH6 epitope was still strongly expressed at the choroid 
plexus, despite an absence of IIH6 expression at the pia mater, and at the sarcolemma in the 
muscle.  In addition, in Large
myd
 mice, IIH6 continued to be expressed throughout epithelial 
structures.  In situ hybridisation data provided by Hewitt (personal communication), 
identified expression of the Large paralogue Large2 in the choroid plexus and in epithelial 
structures outside of the brain. Large2 has been identified as having the same 
xylosyltransferase and glucuronyltransferase activities as Large, but with different 
biochemical properties, most likely accounting for the difference in tissue expression 
observed by Grewal et al. (4, 26, 39).  Interestingly, despite the identification of Large2 
expression at the choroid plexus by in situ hybridisation, expression was not observed in the 
brain with RT-PCR, northern blot or dot blot analysis (26).  The reason for the discrepancy 
between these results is not certain, but may relate to the expression of Large2 by a very 
limited population of cells being “diluted” in the whole brain homogenates used for RT-PCR, 
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northern blot and dot blots. Other than the labelling at the choroid plexus, the expression of 
the IIH6 epitope of alpha dystroglycan appeared to correlate with the expression patterns 
reported by Grewal et al. (26), and was observed exclusively within epithelial structures. 
It is not known how the retention of expression of glycosylated alpha dystroglycan in the 
choroid plexus relates to the relatively mild brain phenotype observed in Large
myd 
mice. 
Studies of embryonic development in Large
myd
 mice have not been published, therefore it is 
not known whether the deficiency in Large is compensated for by the up regulation of 
Large2 at earlier developmental time points. 
This work clearly demonstrates that there is substantial variation in the brain phenotype 
between mouse models of the dystroglycanopathies, indicating that a “one-model-fits-all” 
approach to the investigation of underlying mechanisms is not appropriate, and reiterating 
the importance of both careful model selection, and the use of multiple mouse models, in 
investigative work. Since Cajal-Retzius cells typically respond to cues originating from the 
meninges, our results suggest that whilst cortical defects in Large
myd
 mice are consistent 
with a disturbance of the radial glial scaffold as previously reported, the more severe 
phenotype observed in FKRP
KD
 and Pomgnt1null mice imply additional defects in the 
meninges. Whilst the subplate was not included in the present study, it is comprised of early 
born neurons that are of substantial interest to the present work in that they are generated 
around the same time as the Cajal Retzius cells. Indeed the subplate is a highly dynamic 
structure the transcriptomic profile of which suggests a number of intriguing roles which 
change through development. Future work in this area might profit from an analysis of this 
heterogenous cell population (33).   
It should be noted that whilst the present paper focuses on the role of the pial basement 
membrane in cortical development, neuron:neuron and neuron:glial interactions also play a 
key role in orchestrating development of the cortex. These interactions are mediated by 
integrins, N-cadherin, gap junction proteins together with a number of signaling pathways 
some of which are downstream of reelin (72). Future work may benefit particularly from a 
more detailed exploration of adhesion receptor trafficking which underlies the migration of 
all cells and laminin internalisation in the secondary dystroglycanopathies, the latter of 
which has been shown to utilize dystroglycan in cancer cells (46).  
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In summary our observations implicate gene specific differences in the pathogenesis of 
brain lesions in this group of disorders. Further work is required to identify whether a defect 
in another cell type (such as the leptomeningeal cells) contributes to these phenotypes.  
HSB and SCB designed the study and wrote the paper, HSB, JLW and MH performed the 
experiments and analysed the data. 
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Figure 1: There are substantial histopathological differences in the brain phenotype in FKRP
KD
, 
Pomgnt1null and Large
myd 
mice at P0 
A, B, C, D.  Olfactory lobes and rostral cortex.  In the wild type (A), the organised neocortex is 
apparent dorsal to the olfactory lobes.  In the FKRP
KD
 and Pomgnt1null mice (B and C, respectively) 
the olfactory lobes (OL) are normal, but there is fusion of the cortical hemispheres (arrow head) and 
substantial dyslamination of the rostral neocortex. Cortical disorganisation is most apparent in the 
FKRP
KD
.  In the Large
myd
 (D), the olfactory lobes are again normal.  In these mice the cortical 
hemispheres remain distinct at this level, but do exhibit disruption in lamination. 
E, F, G, H.  Cortex around the level of the corpus callosum.  The cortical plate is distinct, and overlain 
by the cell-poor marginal zone in wild type mice (E).  In the FKRP
KD 
(F), the cortex is completely 
disorganised, and the cortical plate is indistinct.  The Pomgnt1null and Large
myd
 mice (G and H, 
respectively) have well defined cortical plates, but these are overlain by a cell-dense, subarachnoid, 
extracortical layer, which is more pronounced in the Pomgnt1null mice. In Pomgnt1null mice, the 
lateral cortex is more disorganised than the medial cortex (fine arrow). 
I, J, K, L.  Cortex around the level of the hippocampus.  At this level, the FKRP
KD
, POMGnT1null and 
Large
myd
 mice (J, K and L, respectively) all exhibit incomplete formation of the interhemispheric 
fissure with interdigitation of neurons from opposing cortical plates.  In the FKRP
KD
, the remnants of 
the cortical plate are apparent medially, with dyslamination increasing laterally (J, fine arrow).  There 
is ventricular dilation in the FKRP
KD
 and, to a lesser extent the POMGnT1null (*).  In addition, there is 
some rarefaction of the subventricular zone in the FKRP
KD  
only. 
M, N, O, P.  Tectum and cerebellum.  There is disorganisation of the inferior colliculus, most marked 
in the FKRP
KD 
(star).  There is some disruption to the granule cell layer of the cerebellum in the 
FKRP
KD
 and POMGnT1null (N and O, respectively; bold arrow), when compared to the wild type (M).  
The cerebellum in the Large
myd
 (P) does not appear to be affected at this time point. 
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HE. Bars represent 400µm. N = neocortex; OL = olfactory lobes; H = hippocampus; LV = lateral 
ventricles; T = tectum; C = cerebellum.  
Figure 2: Neocortex at the level corpus callosum. 
Neocortex at the level of the corpus callosum.  There is consistent fusion of the cortical hemispheres 
in the FKRP
KD 
(B, F) and the Pomgnt1null (C, G), with interdigitation of neurons from opposing cortical 
plates.  This is not consistently observed in the Large
myd 
at this level (D, H).  The degree of 
disorganisation of the cortical plate varies between models. The cortical plate is inapparent in FKRP
KD 
mice, and no marginal zone is observed.  In Pomgnt1null mice the marginal zone and cortical plate are 
apparent beneath a substantial extracortical layer. The Large
myd
 mice demonstrate a relatively 
organised cortical plate, but multifocally neurons from the cortical plate are apparent migrating 
through the marginal zone and the pial basement membrane and running subjacent and tangential 
to the arachnoid to form a narrow extra cortical layer (fine arrows). The tramline appearance of the 
normal meninges is not present in FKRP
KD
, Pomgnt1null and is only multifocally observed in Large
myd
 
mice. 
HE. A-D – bars represent 400µm; E-F – bars represent 200µm. LV = lateral ventricles; M = 
leptomeninges; MZ = marginal zone; CP = cortical plate; ECL = extra cortical layer. 
Figure 3: Neocortex at the level of the hippocampus. 
For comparison wild type mice are shown in A,E and I. In the neocortex at the level of the 
hippocampus, laminar architecture is most disrupted in FKRP
KD 
mice, (B,F,J) and to a lesser extent, 
Pomgnt1null mice (C,G,K).  The Large
myd
 mice are least affected (D,H,L). Although the cortex is more 
organised at this level than rostrally in FKRP
KD
 mice, there is a distinct lateromedial gradient in 
severity of lesions (bold arrow). There is interdigitation of opposing cortical plates in all mice, 
including the Large
myd
 at this level. Disruption to the hippocampus, particularly the dentate gyrus, 
was present in a proportion of the FKRP
KD
 mice (arrowheads), but was not observed in either the 
Pomgnt1null or the Large
myd
.  
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HE.  A-D - bars represent 400µm; E-H - bars represent 200µm; I-L – bars represent 100µm. N = 
neocortex; H = hippocampus; DG = dentate gyrus; ECL = extracortical layer; CP = cortical plate. 
Figure 4: Midbrain at the level of the inferior colliculus  
Midbrain: Disorganisation is apparent in the superior and inferior colliculi.  For comparison wild type 
mice are shown in A and E. At this level, the phenotype is similar in the Pomgnt1null (C, G) and 
Large
myd 
mice (D,H), with multifocal defects in the pial basement membrane allowing migration of 
neuron and glial cells into the subarachnoid space (chevrons).  In the FKRP
KD
 (B, F) there are appear 
to be more substantial defects in the pial basement membrane laterally (star), allowing a substantial 
layer of neurons to form above the colliculus itself. 
HE. M-P – bars represent 200µm; m-p – bars represent 100µm.  T = tectum; V = ventricle. 
Figure 5A: Immunohistochemical evaluation of the glia limitans.   
A-H. Cortex. BLBP staining of radial glial cells and the glia limitans. The bold arrow indicates the glia 
limitans. In wild type mice, the glia limitans is apparent as a continuous subpial layer (A, E).  The glia 
limitans is disrupted, to varying degrees, in the FKRP
KD
, Pomgnt1null and Large
myd
 (B, C and D 
respectively).  Higher power images show that in the FKRP
KD
 (F) mislocalised radial glial foot 
processes can be observed scattered randomly throughout the cortex.  In Pomgnt1null mice (G), 
multifocal, discontinuous areas of laminar staining are present subjacent to a substantial 
extracortical layer.  Large
myd
 mice (H) have a relatively well formed glia limitans.  There are multifocal 
small defects with migration of the neuroglial cells through the deficits into a narrow extra cortical 
layer. Insets contained within E,F,G,H show higher power magnifications.  A-D – bar represents 
400µm; E-H – bar represents 100µm. N = neocortex; VZ = ventricular zone. 
I-P. Tectum (inferior colliculus).  There is disruption to the glia limitans in the midbrain of the 
FRKRP
KD
, the Pomgnt1null and the Large
myd 
(J, K and L, respectively).  The Pomgnt1null and the Large
myd
 
are histologically similar at this site – there are multifocal defects in the glial limitans (fine arrows), 
with migration of neuroglial cells through the defects to expand the subarachnoid space (O, P).  In 
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addition to multifocal defects, the FKRP
KD
 exhibits disorganisation laterally – laminar BLBP-positive 
foci (radial glial processes) are apparent towards the midline not laterally (star), and there is 
expansion of the subarachnoid space by a substantial population of neuroglial cells (N).  I-L –bar 
represents 400µm; M-P – bar represents 200µm.  T = tectum. 
Figure 5B: Immunohistochemical staining for pan laminin in mouse models of dystroglycanopathy 
A-D. Pan laminin staining of the cortex highlighting the location of the glia limitans (see arrow) in the 
wild type (A), FKRP
KD
 B), Pomgnt1null (C) and Large
myd
 (D).  Higher power images are shown in E-H.  A-
D – bar represents 200µm; E-H – bar represents 100µm. 
 
Figure 6: Immunohistochemical staining for the IIH6 epitope of glycosylated alpha dystroglycan in 
mouse models of dystroglycanopathy 
A, B, C. D. Lateral head sections stained with IIH6 antibody.  The skin, pial basement membrane and 
inner limiting membrane of the eye exhibit strong staining in the wild type, in addition to 
sarcolemmal staining present in the extraocular and subcutaneous muscles (A).  Staining of all of 
these structures is absent in FKRP
KD 
and Pomgnt1null mice (B, C).  In Large
myd 
mice (D), the skin 
remains immunopositive, but staining is absent in other tissues. Bars represent 400µm.  
E, F, G, H.  IIH6 staining in the brain at the level of the hippocampus.  In the WT (E), the basement 
membrane of choroid plexus is strongly immunopositive and there is a narrow, laminar staining 
pattern at the pial basement membrane (arrowheads).  In the FKRP
KD 
and Pomgnt1null mice (F and G, 
respectively), no staining is apparent.  In the Large
myd
, the basement membrane of the choroid 
plexus is strongly immunopositive, but there is no staining at the pial basement membrane. Bars 
represent 200µm. 
HS = haired skin; SCM = subcutaneous muscle; EOM = extraocular muscle; E = eye; N = neocortex; OL 
= olfactory lobe; NC = nasal cavity; CP = choroid plexus. 
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Figure 7: Mislocalisation of the CR cells 
Immunohistochemical staining of the Cajal-Retzius cells with an antibody to reelin, at the level of the 
corpus callosum (A, C, E, G – bar represents 200µm) and at the hippocampus (B, D, F, H – bar 
represents 400µm). In wild type mice there are multifocal, tangentially-orientated, reelin-positive 
Cajal-Retzius cells which form an intermittent, single-cell layer within the marginal zone (A, B).  Large 
numbers of CR cells are present at the hippocampus.  In FKRP
KD
 mice, there is a significant decrease 
in the number f reelin-positive cells at the level of the corpus callosum (C).  Those present are 
disorganised, haphazardly orientated and predominantly clustered around the anterior cerebral 
artery.  At the level of the hippocampus, more normally distributed and orientated CR cells appear 
to be associated with more ordered areas of the cortical plate (D).  In the POMGnT1null mice (E) 
there is less clustering of the CR cells around the anterior cerebral artery.  CR cells extend further 
laterally, although are randomly distributed within the extracortical layer.  Again, CR cell distribution 
appears more normal at the level of the hippocampus (F).  In the Large
myd
 (G) CR cells are orientated 
predominantly transversely (as in the wild type) but are overlain by a narrow extracortical layer, 
rostrally.  There is some disruption in the midline at the level of the hippocampus, in areas of fusion 
of opposing cortical plates (H).  a-d.  Higher magnification views of the cortex at the level of the 
corpus callosum, lateral to the interhemispheric fissure (bars represent 100µm). 
At the level of the corpus callosum (I) there is a statistically-significant decrease in the number of CR 
cells in FKRPKD   (P = 0.0002) and Pomgnt1null mice (P = 0.0017), relative to wild type mice (one way 
ANOVA with Dunnett’s multiple comparisons). This is not observed in Large
myd 
mice (P = 0.986).  At 
the level of the hippocampus (J) in FKRPKD there is a statistically-significant increase in the number 
of CR cells relative to wild type (P = 0.046) but no statistically-significant differences in the number of 
CR cells in either Pomgnt1null or Large
myd
 mice relative to wild type (P = 0.304 and P = 0.930, 
respectively). 
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Figure 1: There are substantial histopathological differences in the brain phenotype in FKRPKD, Pomgnt1null 
and Largemyd mice at P0  
A, B, C, D.  Olfactory lobes and rostral cortex.  In the wild type (A), the organised neocortex is apparent 
dorsal to the olfactory lobes.  In the FKRPKD and Pomgnt1null mice (B and C, respectively) the olfactory lobes 
(OL) are normal, but there is interdigitation of the cortical hemispheres (arrow head) and substantial 
dyslamination of the rostral neocortex. Cortical disorganisation is most apparent in the FKRPKD.  In the 
Largemyd (D), the olfactory lobes are again normal.  In these mice the cortical hemispheres remain distinct at 
this level, but do exhibit disruption in lamination.  
E, F, G, H.  Cortex around the level of the corpus callosum.  The cortical plate is distinct, and overlain by the 
cell-poor marginal zone in wild type mice (E).  In the FKRPKD (F), the cortex is completely disorganised, and 
the cortical plate is indistinct.  The Pomgnt1null and Largemyd mice (G and H, respectively) have well defined 
cortical plates, but these are overlain by a cell-dense, subarachnoid, extracortical layer, which is more 
pronounced in the Pomgnt1null mice. In Pomgnt1null mice, the lateral cortex is more disorganised than the 
medial cortex (fine arrow).  
I, J, K, L.  Cortex around the level of the hippocampus.  At this level, the FKRPKD, POMGnT1null and Large
myd 
mice (J, K and L, respectively) all exhibit interdigitation of  neurons from opposing cortical plates.  In the 
FKRPKD, the remnants of the cortical plate are apparent medially, with dyslamination increasing laterally (J, 
fine arrow).  There is ventricular dilation in the FKRPKD and, to a lesser extent the POMGnT1null (*).  In 
addition, there is some rarefaction of the subventricular zone in the FKRPKD  only.  
M, N, O, P.  Tectum and cerebellum.  There is disorganisation of the inferior colliculus, most marked in the 
FKRPKD (star).  There is some disruption to the granule cell layer of the cerebellum in the FKRPKD and 
POMGnT1null (N and O, respectively; bold arrow), when compared to the wild type (M).  The cerebellum in 
the Largemyd (P) does not appear to be affected at this time point.  
HE. Bars represent 400µm. N = neocortex; OL = olfactory lobes; H = hippocampus; LV = lateral ventricles; 
T = tectum; C = cerebellum.  
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Figure 2: Neocortex at the level corpus callosum.  
Neocortex at the level of the corpus callosum.  There is consistent fusion of the cortical hemispheres in the 
FKRPKD (B, F) and the Pomgnt1null (C, G), with interdigitation of neurons from opposing cortical plates.  This 
is not consistently observed in the Largemyd at this level (D, H).  The degree of disorganisation of the cortical 
plate varies between models. The cortical plate is inapparent in FKRPKD mice, and no marginal zone is 
observed.  In Pomgnt1null mice the marginal zone and cortical plate are apparent beneath a substantial 
extracortical layer. The Largemyd mice demonstrate a relatively organised cortical plate, but multifocally 
neurons from the cortical plate are apparent migrating through the marginal zone and the pial basement 
membrane and running subjacent and tangential to the arachnoid to form a narrow extra cortical layer (fine 
arrows). The tramline appearance of the normal meninges is not present in FKRPKD, Pomgnt1null and is only 
multifocally observed in Largemyd mice.  
HE. A-D – bars represent 400µm; E-F – bars represent 200µm. LV = lateral ventricles; M = leptomeninges; 
MZ = marginal zone; CP = cortical plate; ECL = extra cortical layer.  
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Figure 3: Neocortex at the level of the hippocampus.  
For comparison wild type mice are shown in A,E and I. In the neocortex at the level of the hippocampus, 
laminar architecture is most disrupted in FKRPKD mice, (B,F,J) and to a lesser extent, Pomgnt1null mice 
(C,G,K).  The Largemyd mice are least affected (D,H,L). Although the cortex is more organised at this level 
than rostrally in FKRPKD mice, there is a distinct lateromedial gradient in severity of lesions (bold arrow). 
There is interdigitation of opposing cortical plates in all mice, including the Largemyd at this level. Disruption 
to the hippocampus, particularly the dentate gyrus, was present in a proportion of the FKRPKD mice 
(arrowheads), but was not observed in either the Pomgnt1null or the Large
myd.  
HE.  A-D - bars represent 400µm; E-H - bars represent 200µm; I-L – bars represent 100µm. N = neocortex; 
H = hippocampus; DG = dentate gyrus; ECL = extracortical layer; CP = cortical plate.  
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Figure 4: Midbrain at the level of the inferior colliculus  
Midbrain: Disorganisation is apparent in the superior and inferior colliculi.  For comparison wild type mice 
are shown in A and E. At this level, the phenotype is similar in the Pomgnt1null (C, G) and Large
myd mice ( 
D,H), with multifocal defects in the pial basement membrane allowing migration of neuron and glial cells into 
the subarachnoid space (chevrons).  In the FKRPKD (B, F) there are appear to be more substantial defects in 
the pial basement membrane laterally (star), allowing a substantial layer of neurons to form above the 
colliculus itself.  
HE. M-P – bars represent 200µm; m-p – bars represent 100µm.  T = tectum; V = ventricle.  
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Figure 5B: Immunohistochemical staining for pan laminin to show the glia limitans. A-D. Pan laminin 
staining of the cortex at the level of the corpus callosum highlighting the location of the glia limitans (see 
arrow) in the wild type (A), FKRPKD B), Pomgnt1null (C) and Largemyd (D).  Higher power images are shown in 
E-H.  A-D – bar represents 200µm; E-H – bar represents 100µm.  
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Figure 6. Immunohistochemical staining for the IIH6 epitope of glycosylated alpha dystroglycan in mouse 
models of dystroglycanopathy  
A, B, C. D. Lateral head sections stained with IIH6 antibody.  The skin, pial basement membrane and inner 
limiting membrane of the eye exhibit strong staining in the wild type, in addition to sarcolemmal staining 
present in the extraocular and subcutaneous muscles (A).  Staining of all of these structures is absent in 
FKRPKD and Pomgnt1null mice (B, C).  In Large
myd mice (D), the skin remains immunopositive, but staining is 
absent in other tissues. Bars represent 400µm.  
E, F, G, H.  IIH6 staining in the brain at the level of the hippocampus.  In the WT (E), the basement 
membrane of choroid plexus is strongly immunopositive and there is a narrow, laminar staining pattern at 
the pial basement membrane (arrowheads).  In the FKRPKD and Pomgnt1null mice (F and G, respectively), no 
staining is apparent.  In the Largemyd, the basement membrane of the choroid plexus is strongly 
immunopositive, but there is no staining at the pial basement membrane. Bars represent 200µm.  
HS = haired skin; SCM = subcutaneous muscle; EOM = extraocular muscle; E = eye; N = neocortex; OL = 
olfactory lobe; NC = nasal cavity; CP = choroid plexus.  
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Figure 7: Mislocalisation of the CR cells  
Immunohistochemical staining of the Cajal-Retzius cells with an antibody to reelin, at the level of the corpus 
callosum (A, C, E, G – bar represents 200µm) and at the hippocampus (B, D, F, H – bar represents 400µm). 
In wild type mice there are multifocal, tangentially-orientated, reelin-positive Cajal-Retzius cells which form 
an intermittent, single-cell layer within the marginal zone (A, B).  Large numbers of CR cells are present at 
the hippocampus.  In FKRPKD mice, there is a significant decrease in the number of reelin-positive cells at 
the level of the corpus callosum (C).  Those present are disorganised, haphazardly orientated and 
predominantly clustered around the anterior cerebral artery.  At the level of the hippocampus, more 
normally distributed and orientated CR cells appear to be associated with more ordered areas of the cortical 
plate (D).  In the POMGnT1null mice (E) there is less clustering of the CR cells around the anterior cerebral 
artery.  CR cells extend further laterally, although are randomly distributed within the extracortical 
layer.  Again, CR cell distribution appears more normal at the level of the hippocampus (F).  In the Largemyd 
(G) CR cells are orientated predominantly transversely (as in the wild type) but are overlain by a narrow 
extracortical layer, rostrally.  There is some disruption in the midline at the level of the hippocampus, in 
areas of fusion of opposing cortical plates (H).  a-d.  Higher magnification views of the cortex at the level of 
the corpus callosum, lateral to the interhemispheric fissure (bars represent 100µm).  
At the level of the corpus callosum (I) there is a statistically-significant decrease in the number of CR cells in 
FKRPKD   (P = 0.0002) and Pomgnt1null mice (P = 0.0017), relative to wild type mice (one way ANOVA with 
Dunnett’s multiple comparisons). This is not observed in Largemyd mice (P = 0.986).  At the level of the 
hippocampus (J) in FKRPKD there is a statistically-significant increase in the number of CR cells relative to 
wild type (P = 0.046) but no statistically-significant differences in the number of CR cells in either 
Pomgnt1null or Largemyd mice relative to wild type (P = 0.304 and P = 0.930, respectively).  
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